The ACHIEVE visual abstract

Does spironolactone decrease cardiovascular disease and heart failure hospitalizations in patients on dialysis?

Check out this crisp VA by Dr Akshaya Jayachandran.

Ensayo HiLo: el resumen visual

Aunque sabemos que el fósforo elevado se asocia consistentemente con mayor mortalidad y eventos cardiovasculares, aún no existe evidencia definitiva de que bajarlo de forma agresiva cambie el pronóstico.

Revisemos el resumen visual del estudio HiLo, creado Sejal Lakhani que evaluó objetivos altos vs. bajos de fósforo sérico en pacientes en hemodiálisis.

The HiLo Trial - Visual Abstract

Is a lower versus higher phosphate target beneficial to patients undergoing hemodialysis?

Check out this crisp VA by Dr Sejal Lakhani

View fullsize

eGFR perspectives on the difference between Cystatin C and creatinine

Check out the summary on eGFR diference chat, done by NephJC intern Bogdan Agavriloaei

Las Perspectivas del estudio CRIC: el Resumen Visual

Basado en los datos del estudio CRIC, este análisis profundiza en si esa discordancia (TFGe dif) es solo “ruido”… o una señal clínica que hemos estado ignorando.

Echale un vistazo al resumen visual realizado por el equipo de internos de #NephJC Dr Sai Vani Yellampalli y Akshaya Jayachandran

View fullsize

Insights from the CRIC Study: Visual Abstract

Based on data from the CRIC study, this analysis dives deep into whether this lab mismatch is just noise… or a clinical signal we’ve been missing.

Check out the beautiful visual abstract made by our NephJC interns Sai Vani Yellampalli and Akshaya Jayachandran. Great team work!!!

View fullsize

CONFIDENCE manifests: finerenone & empagliflozin – CKD power couple that’s redefining ‘renal romance’

Check out CONFIDENCE recap

CONFIDENCE Visual Abstract

Check out the beautiful visual abstract made by NephJC intern Michelle Fravel.

View fullsize

Resumen Visual Ensayo CONFIDENCE

El ensayo CONFIDENCE evaluó la combinación de finerenona + empagliflozina en ERC + DM2: mayor reducción de CACu a 180 días. ¿Estamos listos para iniciar la terapia combinada desde el principio?

Revisa el resumen visual por Michelle Fravel

View fullsize

Introducing NephJC Shorts

In just over a decade of critical appraisal on NephJC, we have done several experiments. Some of them have worked out phenomenally well, such as the Freely Filtered podcast. Others were not ready for the time, such as the Google Hangouts. We want to try another such experiment, and hope we receive feedback to decide if this is something worthwhile that we should continue doing.

There are many studies and many trials and many reviews, and many guidelines that are published in Nephrology every week. Indeed, it is a golden era for randomized controlled trials in Nephrology. On the other hand, NephJC only occurs twice a month. It does take a lot of work, with the detailed critical appraisal, readable summary, visual, abstracts, and the chats. Sometimes the occasional, irregularly irregular podcast. Hence, we cannot deal with all the worthwhile studies that are coming out.

Enter NephJC Shorts. 

This week, we are publishing a few short blogs. The purpose here is to cover some notable studies in brief. They do not receive the full, long, NephJC treatment. The articles we choose are those that the NephJC editorial team fancies, but suggestions are welcome. Since these are a shorter format, we don’t do a deep dive into the methods and don’t have a long list of the limitations and strengths. Think of them as a pithy version of the usual NephJC blog. Feedback welcome! 

The NephJC Editors